Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-29 9:51 pm Unchanged | 13D | MOLECULAR TEMPLATES INC MTEM | Longitude Capital Partners III LLC | 310,052 4.6% | 0 (Unchanged) | View |
| 2024-04-02 9:56 pm Purchase | 13D | MOLECULAR TEMPLATES INC NE MTEM | SANTE HEALTH VENTURES I LP | 665,538 10.1% | 665,538 (New Position) | View |
| 2024-02-14 8:39 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | SILVERARC CAPITAL MANAGEMENT LLC | 354,608 6.6% | 354,608 (New Position) | View |
| 2024-02-14 4:45 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | K2 HealthVentures Equity Trust LLC | 596,145 9.985% | 596,145 (New Position) | View |
| 2024-02-14 2:03 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | LYTTON LAURENCE W | 232,951 4.3% | 232,951 (New Position) | View |
| 2024-02-14 09:33 am Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | BIOTECHNOLOGY VALUE FUND L P | 537,426 9.99% | 537,426 (New Position) | View |
| 2024-02-13 11:00 am Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | BB BIOTECH AG | 1,029,820 19.2% | 1,029,820 (New Position) | View |
| 2023-10-23 5:42 pm Sale | 13D | MOLECULAR TEMPLATES INC MTEM | Longitude Capital Partners III LLC | 310,052 5.7% | -4,340,745 (-93.33%) | View |
| 2023-07-20 5:09 pm Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | LYTTON LAURENCE W | 4,142,361 5.1% | 4,142,361 (New Position) | View |
| 2023-07-18 3:05 pm Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,391,489 5.45% | 4,391,489 (New Position) | View |
| 2023-06-26 5:27 pm Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | K2 HealthVentures Equity Trust LLC | 6,250,860 9.985% | 6,250,860 (New Position) | View |
| 2023-02-14 4:24 pm Sale | 13D | MOLECULAR TEMPLATES INC MTEM | Longitude Capital Partners III LLC | 4,650,797 8% | -53,154 (-1.13%) | View |
| 2023-02-14 4:13 pm Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | BB BIOTECH AG | 11,192,003 19.9% | 400,000 (+3.71%) | View |
| 2023-02-13 8:09 pm Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | BIOTECHNOLOGY VALUE FUND L P | 5,246,565 9.3% | 1,866,966 (+55.24%) | View |
| 2023-02-03 11:58 am Sale | 13G | MOLECULAR TEMPLATES INC MTEM | PICTET ASSET MANAGEMENT SA | 1,802,753 3.2% | -1,498,266 (-45.39%) | View |
| 2022-03-09 5:18 pm Sale | 13G | MOLECULAR TEMPLATES INC MTEM | BlackRock Inc. BLK | 2,814,461 4.99% | -36,440 (-1.28%) | View |
| 2022-02-14 1:30 pm Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | BIOTECHNOLOGY VALUE FUND L P | 3,379,599 6% | 618,478 (+22.40%) | View |
| 2022-02-11 4:49 pm Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | BB BIOTECH AG | 10,792,003 19.2% | 1,249,382 (+13.09%) | View |
| 2022-02-10 11:06 am Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | PICTET ASSET MANAGEMENT SA | 3,301,019 5.86% | 3,301,019 (New Position) | View |
| 2022-02-04 4:12 pm Sale | 13G | MOLECULAR TEMPLATES INC MTEM | BlackRock Inc. BLK | 2,850,901 5.1% | -227,808 (-7.40%) | View |